FDA-approved gout medicine could also battle COVID-19

As COVID-19 cases continue to skyrocket across the U.S. and the world, few options are available for treating patients infected with the SARS-CoV-2. But new research from the University of Georgia found that probenecid has broad antiviral properties, making it a prime candidate to combat not only SARS-CoV-2 infection but also other common and deadly respiratory viruses like RSV and flu.

See full story here: https://news.uga.edu/gout-medicine-could-also-battle-covid-19/

Get in Touch

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related Articles

Latest Posts

Subscribe To Our Newsletter

Keep up with the latest Boomer news and events, curated with the interests of the over-50 community in mind. We won't clutter your inbox, but you'll get our email a couple of times a month so you won't miss anything.

You have Successfully Subscribed!